Prevalence of anemia in type II diabetes mellitus patients


  • Sreenivas Reddy Department of General Medicine, Nimra Institute of Medical Sciences, Vijayawada, Andhra Pradesh, India
  • Molugu Divya Reddy Department of General Medicine, Nimra Institute of Medical Sciences, Vijayawada, Andhra Pradesh, India



Anemia, Diabetes, Prevalence


Background: Anemia is a common haematological finding in diabetic patients. The prevalence of anemia in the patients with diabetes is two or three times higher than in patients with comparable renal impairment and iron stores in the general population. As India is foreseen a diabetic capital of the world, it becomes imperative to recognize co-morbidities such as anemia at the earliest. The aim of this study was to determine the prevalence of anemia among patients with type 2 diabetes. Author conducted a prospective analysis of 100 diabetic patients visiting the outpatient clinic in our institution. Duration of study is One Year (November 2016 - December 2017). Study perform at Om Sai Hospitals, Balapur, Hyderabad, Telangana, India. A 100 patients suffering from type 2 Diabetes Mellitus, attending Outpatient Department of General Medicine, were included in the study.

Methods: All the patients were subjected to detailed history, through clinical examination and investigation. Patients’ blood samples were analyzed for Glycated hemoglobin (HbA1C) values and hemoglobin (Hb) levels. The prevalence of anemia was then determined defining anemia by an Hb level <13.0 g/dL for men and <12.0 g/dL for women.

Results: The prevalence of anemia in this study population was found to be 43%. The prevalence of anemia is significantly greater in diabetic females than in diabetic males and in poorly controlled diabetics than those with glycemic status under control.

Conclusions: We conclude that anemia is a prevalent finding in patients with type 2 diabetes mellitus and represents significant unrecognised burden.


Maitra A, Abbas AK. Endocrine system. In: Kumar V, Fausto N, Abbas AK, eds. Robbins and Cotran Pathologic basis of disease. 7th ed. Philadelphia, Saunders; 2005: 1156-1226.

Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives. Nature Reviews Endocrinol. 2012 Apr;8(4):228.

Genetic basis of type 1 and type 2 diabetes, obesity, and their complications. Advances and emerging opportunities in diabetes research: a Strategic Planning report of the DMICC.

Azevedo M, Alla S. Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia. Int J Diabetes Devel Countr. 2008 Oct;28(4):101.

Global burden of diabetes. International Diabetes federation. Diabetic atlas; Brussels. 5th Edition; 2011.

Silva TR, Zanuzzi J, Silva CDM, Passos XS, Costa BMF. Prevalence of cardiovascular diseases in diabetic and nutritional status of patientes. J Health Sci Inst. 2012;30(3):266-70.

Angelousi A, Larger E. Anaemia, a common but often unrecognized risk in diabetic patients: a review. Diabetes Metabolism. 2015;41(1):18-27.

Martínez-Pérez B, De La Torre-Díez I, López-Coronado M. Mobile health applications for the most prevalent conditions by the World Health Organization: review and analysis. J Med Inter Res. 2013;15(6):e120.

Fava S, Azzopardi J, Ellard S, Hattersley AT. ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease. Diabetes Care. 2001;24(12):2115-2120.

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW. Chronic kidney disease: global dimension and perspectives. Lancet. 2013 Jul 20;382(9888):260-72.

Escorcio CS, Silva HF, Junior GB, Monteiro MP, Gonçalves RP. Evaluation of anemia treatment with EPO and oral and iv iron in patients with chronic kidney disease under hemodialysis. RBSA. 2010;42(2):87-90.

Weiss G, Goodnough LT. Anemia of chronic disease. New Eng J Med. 2005 Mar 10;352(10):1011-23.

Macdougall IC, Eckardt KU, Locatelli F. Latest US KDOQI Anaemia Guidelines update-what are the implications for Europe?. Nephrology Dialysis Transplantation. 2007;22(10):2738-2742.

MacCiò A, Madeddu C. Management of anemia of inflammation in the elderly. Anemia. 2012;2012:20.

Moreira TD, Mascarenhas MA. Avaliação da prevalência de anemia em grupos Diabéticos e não Diabéticos e sua relação com insuficiência renal crônica. NewsLab. 2004;62:84-90.

Singh DK, Winocour P, Farrington K. Erythropoietic stress and anemia in diabetes mellitus. Nature Reviews Endocrinol. 2009 Apr;5(4):204-10.

WHO. Anaemia. World Health Organization; 2012.

Alsayegh F, Waheedi M, Bayoud T, Al Hubail A, Al-Refaei F, Sharma P. Anemia in diabetes: Experience of a single treatment center in Kuwait. Primary Care Diabetes. 2017 Aug 1;11(4):383-8.

Lipschitz DA. Screening for nutritional status in the elderly. Primary Care. 1994 Mar;21(1):55-67.

Hevward VH, Stolarczyc LM. Avaliação da composição corporal aplicada. São Paulo, Brazil: Manole; 2000.




How to Cite

Reddy, S., & Reddy, M. D. (2019). Prevalence of anemia in type II diabetes mellitus patients. International Journal of Research in Medical Sciences, 7(9), 3536–3539.



Original Research Articles